Abstract:Interleukin-2 is one of the lymphokines secreted by T helper type 1 cells upon activation mediated by T-cell receptor (TCR) and accessory molecules. The ability to express IL-2 is correlated with T-lineage commitment and is regulated during T cell development and differentiation. Understanding the molecular mechanism of how IL-2 gene inducibility is controlled at each transition and each differentiation process of T-cell development is to understand one aspect of T-cell development. In the present study, we first attempted to elucidate the molecular basis for the developmental changes of IL-2 gene inducibility. We showed that IL-2 gene inducibility is acquired early in immature CD4- CD8-TCR- thymocytes prior to TCR gene rearrangement. Similar to mature T cells, a complete set of transcription factors can be induced at this early stage to activate IL-2 gene expression. The progression of these cells to cortical CD4^+CD8^+TCR^(1o) cells is accompanied by the loss of IL-2 gene inducibility. We demonstrated that DNA binding activities of two transcription factors AP-1 and NF-AT are reduced in cells at this stage. Further, the loss of factor binding, especially AP-1, is attributable to the reduced ability to activate expression of three potential components of AP-1 and NF-AT, including c-Fos, FosB, and Fra-2. We next examined the interaction of transcription factors and the IL-2 promoter in vivo by using the EL4 T cell line and two non-T cell lines. We showed an all-or-none phenomenon regarding the factor-DNA interaction, i.e., in activated T cells, the IL-2 promoter is occupied by sequence-specific transcription factors when all the transcription factors are available; in resting T cells or non-T cells, no specific protein-DNA interaction is observed when only a subset of factors are present in the nuclei. Purposefully reducing a particular set of factor binding activities in stimulated T cells using pharmacological agents cyclosporin A or forskolin also abolished all interactions. The results suggest that a combinatorial and coordinated protein-DNA interaction is required for IL-2 gene activation. The thymocyte experiments clearly illustrated that multiple transcription factors are regulated during intrathymic T-cell development, and this regulation in tum controls the inducibility of the lineage-specific IL-2 gene. The in vivo study of protein-DNA interaction stressed the combinatorial action of transcription factors to stably occupy the IL-2 promoter and to initiate its transcription, and provided a molecular mechanism for changes in IL-2 gene inducibility in T cells undergoing integration of multiple environmental signals.

T cell activation through TCR/-CD3 complex. IL-2 production of T cell clones stimulated with anti-CD3 without cross-linkage.

Il-12 Augments Antigen-Dependent Proliferation Of Activated Lymphocytes-T

Costimulatory requirements of murine Th1 clones. The role of accessory cell-derived signals in responses to anti-CD3 antibody.

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.

IL‐2 amplifies quantitative TCR signalling inputs to drive Th1 and Th2 differentiation

Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.

Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function

Lymphokine activation of T4+ T lymphocytes and monocytes.

T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds

CD4 ligand IL-16 inhibits the mixed lymphocyte reaction.

The Novel Non-Mitogenic Anti-Cd3 Antibody, Mini-Ycd3, Delivers a Partial TCR Signal

Molecular Mechanisms of Interleukin-2 Gene Inducibility: Developmental Control and Combinatorial Action of Transcription Factors

Stimulation of T cells through the CD3/T-cell receptor complex: role of cytoplasmic calcium, protein kinase C translocation, and phosphorylation of pp60c-src in the activation pathway

Soluble Peptide–mhc Monomers Cause Activation of CD8+T Cells Through Transfer of the Peptide to T Cell MHC Molecules

Human peripheral blood T helper cell-induced B cell activation results in B cell surface expression of the CD23 (BLAST-2) antigen

IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation.

Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression

Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.

Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes